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. In both acquired and congenital heart disease, defects in these intracellular structures contribute to systolic dysfunction and heart failure (HF) (3) (4) (5) . Here, we identify an unexpected requirement of cardiac AnkG for normal cardiac structure and function. We illustrate in both humans and mice a striking change in AnkG levels during key stages of cardiac remodeling both in compensatory hypertrophy and in end-stage dilated cardiomyopathy. Moreover, the key role of AnkG in cardiac remodeling is supported by studies in mice lacking cardiac AnkG expression. Functional data were derived from the M-mode measurements, including fractional shortening and ejection fraction.
A B B R E V I A T I O N S
HISTOLOGY. Hearts were explanted and fixed in 10% formalin, processed, and then embedded into paraffin for sectioning. Hearts were sectioned along the long axis (4-chamber view) at a thickness of 10 mm. Sections were stained with hematoxylin and eosin to examine general structure and histology, and with
Masson's trichrome to visualize collagen deposition (fibrosis).
TUNEL STAINING. Paraffin-embedded heart sections were deparaffinized with xylene followed by 
RESULTS

AnkG EXPRESSION IS ALTERED IN HUMAN HF.
Several reports have documented dysregulated 1D and 1E) . Thus, AnkG expression is altered in human HF. which the heart is actively undergoing compensatory N-cadherin (green) and AnkG staining (red) in the left ventricle of (A) non-failing human heart, as well as hearts from individuals with (B) ischemic HF and (C) nonischemic HF. In A, arrows note strong localization of AnkG at the intercalated disc. In B and C, asterisks denote AnkG loss. Nuclei are visualized in blue (bar ¼ 10 mm). Immunoblot analysis demonstrates a decrease in total AnkG expression in (D) ischemic and (E) nonischemic heart failure compared with nonfailing hearts (n ¼ 3 NF; n ¼ 5 IHF; n ¼ 5 NIHF; p < 0.05). AnkG ¼ ankyrin-G; HF ¼ heart failure; IHF ¼ ischemic heart failure; NF ¼ nonfailing; NIHF ¼ nonischemic heart failure. 3C , and 3E) and increased heart weight/tibia length ratio ( Figure 3D) Makara et al. 
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Ankyrin-G Regulates Cardiac Structure presence of vacuolization in AnkG cKO hearts, compared with control animals ( Figures 4H and 4I ).
Although we observed an increase in myocyte crosssectional area in control hearts 2 weeks post-TAC, supporting concentric hypertrophy at the cellular level, AnkG cKO hearts did not display increased cross-sectional area 2 weeks post-TAC (Supplemental Figure 3A) indicating a lack of significant concentric hypertrophy. We observed no significant difference in cell death (TUNEL-positive myocytes) between genotypes either at baseline or following the 2-week TAC protocol (Supplemental Figure 3B ).
AnkG cKO mice demonstrated a severe reduction in systolic function already at 2 weeks follow-up post-TAC ( Figure 4J ). LV chamber size and systolic function were decreased in cKO mice compared with control animals at baseline (Figures 4J to 4L) . However, at 2 weeks post-TAC, AnkG cKO animals already Makara et al.
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Ankyrin-G Regulates Cardiac Structure PKP2 expression was significantly increased in the setting of pressure overload ( Figure 7D ). However, following 2 weeks TAC, PKP2 expression in AnkG cKO hearts doubled from AnkG cKO baseline ( Figure 7D ).
Further, PKP2 expression in AnkG cKO TAC animals was increased relative to WT TAC control animals ( Figure 7D ). Immunostaining revealed that unlike in control myocytes where PKP2 is enriched at the intercalated disc, PKP2 is redistributed throughout the cytosol of AnkG cKO mice with significant perinuclear localization ( Figures 7E to 7H , Supplemental Figure 4 ). PKP2 mislocalization was exacerbated by Makara et al.
intercalated disc localization in the absence of AnkG.
Further, we observed no significant differences in the expression or localization of b-catenin, aII-spectrin, or a-tubulin between control and AnkG cKO hearts at baseline or 2 weeks post-TAC.
Finally, we examined desmin, the final downstream node for integration of the desmosome with the intermediate filament network. We observed no significant change in total desmin levels regardless of genotype or treatment condition (Supplemental Figure 6) . Further, the 2-week TAC protocol produced minimal changes in desmin organization in WT mice (Supplemental Figure 6 ). However, in AnkG cKO hearts, we observed a significant reduction in desmin localization at the cardiac intercalated disc (Supplemental Figure 6 ). This loss was pronounced in the TAC animals. Thus, the loss of AnkG has a profound impact on critical cardiac regulatory proteins, including DSP, PKP2, and desmin. 
